Brief: Med BioGene Inc announces commercialization status of Genefx Lung(R)
Dec 15 (Reuters) - Med BioGene Inc MBI.V : * Licensee, Helomics advised logistical procedures necessary for the first commercial application of Genefx lung will commence Q1 2016 * Source text for Eikon ID:nMKWjHrJda * Further company coverage MBI.V ((Bengaluru Newsroom; +1 646 223 8780))